OpenVSafe by OpenVAERS
Search V-safe

2MA-29038-10878

2 vaccinations 11 coded responses 26 check-ins 10 free-text entries 5 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
543 / WI
Registered
2021-04-09
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-08
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-04-09
    Registered in v-safe
  3. 2021-04-09
    Survey response — days 1–6 daily, dose 1
    MedDRA: Facial pain, Pain in jaw, Rhinalgia — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Pain in facial area (nasal and jaw pain)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: Back pain, Facial pain, Muscular weakness, Pain in jaw, Rhinalgia — Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Facial pain (nasal and jaw), back pain, and left leg weakness still persist
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  7. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  8. 2021-04-15
    Health check-in — day 7, dose 1
    Feeling: Fair · Site: Itching · Chills, Headache, Joint pains, Muscle or body aches, Rash, not including the immediate area around the injection site
    Adult check-in
  9. 2021-04-22
    Survey response — day 14, dose 1
    MedDRA: Chronic fatigue syndrome, Migraine, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Worsting of migraines and chronic fatigue syndrome
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-29
    Health check-in — day 21, single dose
    Feeling: Good
    Adult check-in
  11. 2021-05-06
    Survey response — day 28, single dose
    MedDRA: Condition aggravated, Fatigue, Migraine, Neck pain, Pain in jaw, Pre-existing disease — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Worsting migraines, neck and jaw pain, as well as chronic fatigue syndrome.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-05-06
    Report sent to call center — day 28, single dose
    Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-05-13
    Health check-in — day 35, single dose
    Feeling: Fair
    Adult check-in
  14. 2021-05-20
    Survey response — day 42, single dose
    MedDRA: Back pain, Headache — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Worsening headaches, and back pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-05-20
    Report sent to call center — day 42, single dose
    Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-05-27
  17. 2021-07-08
    Survey response — 3 months, dose 1
    MedDRA: Migraine — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Migraines became worst
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-07-08
    Report sent to call center — 3 months, dose 1
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-07-12
  20. 2021-07-15
  21. 2021-10-08
    Survey response — 6 months, dose 1
    MedDRA: Chest pain, Dysphagia, Dyspnoea — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Chest pains, difficulty breathing, difficulty swallowing.
    MedDRA releases: 2024-11 · check-in free text available
  22. 2021-10-08
    Report sent to call center — 6 months, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  23. 2021-10-11
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  24. 2022-01-21
    Dose 2 — Pfizer-BioNTech
  25. 2022-01-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain — Feeling: Poor · Site: Pain, Swelling · Joint pains, Muscle or body aches
    Free text: Pain in armpit
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  27. 2022-01-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  28. 2022-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  29. 2022-01-29
    Health check-in — day 7, dose 2
    Feeling: Poor · Headache, Fatigue or tiredness
    Adult check-in
  30. 2022-02-05
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  31. 2022-02-11
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  32. 2022-02-19
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  33. 2022-03-01
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  34. 2022-03-07
    Survey response — day 42, dose 2
    MedDRA: Diarrhoea, Nausea — Feeling: Fair
    Free text: Nausea and diarrhea
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-04-22
    Survey response — 3 months, dose 2
    MedDRA: Rash, Thyroidectomy, Viral rash — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Rashes on entire body (viral rash), no antibiotics. Thyroidectomy on April 8, 2022.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-04-22
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  37. 2022-04-25
  38. 2022-07-26
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  39. 2023-01-24
    Survey response — 12 months, dose 2
    MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Fair
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-04-08Janssen/Johnson & Johnson
22022-01-21Pfizer-BioNTech No

Call center

5 call center cases

4 successful · 1 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-09

Systemic reaction (other): Pain in facial area (nasal and jaw pain)

2021-04-10

Systemic reaction (other): Facial pain (nasal and jaw), back pain, and left leg weakness still persist

Release 7 — day 14, dose 1

2021-04-22

Symptoms: Worsting of migraines and chronic fatigue syndrome

Release 8 — day 28, single dose

2021-05-06

Symptoms: Worsting migraines, neck and jaw pain, as well as chronic fatigue syndrome.

Release 8 — day 42, single dose

2021-05-20

Symptoms: Worsening headaches, and back pain

Release 9 — 3 months, dose 1

2021-07-08

Symptoms: Migraines became worst

Release 10 — 6 months, dose 1

2021-10-08

Symptoms: Chest pains, difficulty breathing, difficulty swallowing.

Release 11 — days 1–6 daily, dose 2

2022-01-23

Systemic reaction (other): Pain in armpit

Release 11 — day 42, dose 2

2022-03-07

Symptoms: Nausea and diarrhea

Release 11 — 3 months, dose 2

2022-04-22

Symptoms: Rashes on entire body (viral rash), no antibiotics. Thyroidectomy on April 8, 2022.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBack pain ✓ ✓ ✓
SDChest pain · · ✓
SDChronic fatigue syndrome ✓ ✓ ✓
SDCondition aggravated ✓ ✓ ✓
SDDiarrhoea · · ✓
SDDysphagia · · ✓
SDDyspnoea · · ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDMigraine ✓ ✓ ✓
SDNasal congestion · · ✓
SDNausea · · ✓
SDNeck pain ✓ ✓ ✓
SDPain in jaw ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDRash · · ✓
SDRhinorrhoea · · ✓
SDThyroidectomy · · ✓
SDViral rash · · ✓
SROAxillary pain · · ✓
SROBack pain ✓ ✓ ✓
SROFacial pain ✓ ✓ ✓
SROMuscular weakness ✓ ✓ ✓
SROPain in jaw ✓ ✓ ✓
SRORhinalgia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release